Adviser Investments LLC Pfizer Inc Transaction History

Adviser Investments LLC

$7.95 Billion
Q3 2024

A detailed history of Adviser Investments LLC transactions in Pfizer Inc stock. As of the latest transaction made, Adviser Investments LLC holds 666,329 shares of PFE stock, worth $17.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

666,329

Previous 272,038 144.94%

Holding current value

$17.3 Million

Previous $7.61 Million 153.36%

% of portfolio

0.24%

Previous 0.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $10.9 Million - $12.4 Million	394,291 Added 144.94%	666,329 $19.3 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $370,968 - $434,705	-14,686 Reduced 5.12%	272,038 $7.61 Million
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $119,094 - $136,758	-4,600 Reduced 1.58%	286,724 $7.96 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $5.06 Million - $6.58 Million	193,726 Added 198.49%	291,324 $8.39 Million
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $118,925 - $139,012	3,706 Added 3.95%	97,598 $3.24 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $2.45 Million - $2.83 Million	67,706 Added 258.56%	93,892 $3.44 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $101,429 - $132,046	2,575 Added 10.91%	26,186 $1.07 Million
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $59,243 - $77,335	-1,419 Reduced 5.67%	23,611 $0
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $122,703 - $149,789	-2,804 Reduced 10.07%	25,030 $1.1 Million
Q2 2022 Jul 14, 2022	BUY	$46.53 - $55.17 $105,762 - $125,401	2,273 Added 8.89%	27,834 $1.46 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $46,070 - $57,086	1,007 Added 4.1%	25,561 $1.32 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $20,205 - $29,951	489 Added 2.03%	24,554 $1.45 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $14,522 - $18,655	-370 Reduced 1.51%	24,065 $1.04 Million
Q2 2021 Jul 09, 2021	SELL	$35.91 - $40.68 $17,164 - $19,445	-478 Reduced 1.92%	24,435 $957,000
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $9,645 - $10,877	-288 Reduced 1.14%	24,913 $903,000
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $5.23 Million - $6.65 Million	-156,247 Reduced 86.11%	25,201 $928,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $276,637 - $324,559	-8,713 Reduced 4.58%	181,448 $6.66 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $54,276 - $65,845	1,802 Added 0.96%	190,161 $6.22 Million
Q1 2020 Apr 08, 2020	SELL	$27.03 - $38.62 $164,937 - $235,659	-6,102 Reduced 3.14%	188,359 $6.15 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $125,820 - $142,789	3,822 Added 2.0%	194,461 $7.62 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $52,763 - $68,419	1,624 Added 0.86%	190,639 $6.85 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $1.93 Million - $2.17 Million	52,276 Added 38.23%	189,015 $8.19 Million
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $50,137 - $55,084	1,337 Added 0.99%	136,739 $5.81 Million
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $100,599 - $114,693	2,615 Added 1.97%	135,402 $5.91 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $86,140 - $104,483	-2,499 Reduced 1.85%	132,787 $5.85 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $105,371 - $112,336	-3,195 Reduced 2.31%	135,286 $4.91 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $725,505 - $841,686	-22,736 Reduced 14.1%	138,481 $4.92 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $395,228 - $419,351	11,883 Added 7.96%	161,217 $5.84 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $526,783 - $580,310	16,993 Added 12.84%	149,334 $5.33 Million
Q2 2017 Aug 14, 2017	BUY	N/A	132,341	132,341 $4.45 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Account

Adviser Investments LLC Pfizer Inc Transaction History